Innovating Works

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA

Activa
Mostrando 1 al 20 de 319 resultados
EASIGEN-DS: DESIGN STUDY FOR A EUROPEAN INFRASTRUCTURE ON ADVANCED GENOMICS TECHNOLOGIES CONSORCIO PARA LA EXPLOTACION DEL CENTRO NACIONAL DE ANALISIS GENOMICO tramitó un HORIZON EUROPE: Innovation in the genomics field is extremely intense and requires high up-front investments. The toolbox of sequencing platforms with uniqu...
2024-10-09 - 2028-01-31 | Financiado
tRNADiagnostics: Simple and cost effective cancer diagnosis in liquid biopsy through native tRNA sequencing FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un HORIZON EUROPE: Transfer RNAs (tRNAs) are abundant, heavily-modified small non-coding RNAs that play a pivotal role in decoding genetic information, determi...
2024-10-04 - 2026-06-30 | Financiado
Nanodesign: Computer aided de novo design of nanobodies FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un HORIZON EUROPE: Antibodies have become major players in the pharmaceutical industry and were valued at 0.16 US billion in 2023. Traditionally, antibodies a...
2024-10-03 - 2026-04-30 | Financiado
INTERACT: Interdisciplinary Marie Sk odowska Curie Action for Health KOBENHAVNS UNIVERSITET tramitó un HORIZON EUROPE: The last decades are characterised by great breakthroughs in the understanding, diagnosing, and treating of many diseases. As fields advance...
2024-09-13 - 2030-08-31 | Financiado
VIDA: VHIO International postDoctoral programme for translAtional research FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: The proposed VHIO International postDoctoral programme for translAtional research (VIDA) aims at enabling outstanding junior scientists of a...
2024-09-12 - 2029-12-31 | Financiado
ARISE2: Career Accelerator for Research Infrastructure Scientists 2nd generation EUROPEAN MOLECULAR BIOLOGY LABORATORY tramitó un HORIZON EUROPE: The ARISE2 program will train 50 postdoctoral fellows for roles as research infrastructure (RI) scientists—highly skilled and much-needed sc...
2024-09-12 - 2029-12-31 | Financiado
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
NUCLEAR: METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS tramitó un HORIZON EUROPE: NUCLEAR aims at educating future experts that can drive the emerging field of Metabolic Regulation of Genome Function and Cell Identity rele...
2024-06-25 - 2029-02-28 | Financiado
GenomeDia: GenomeDia a personalized medicine tool for diabetes FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un HORIZON EUROPE: Diabetes Mellitus affects nearly 600 million people worldwide. It is a major cause of premature death, blindness, end stage kidney disease,...
2024-06-06 - 2026-01-31 | Financiado
BIOMICS: Fostering Excellent Research, Training and Innovation in Biomedical Data Science INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES tramitó un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 The Instituto de Medicina Molecular João Lobo Antunes (iMM) is a leading European institute in basic biomedical research, now establishing a...
2024-05-22 - 2027-09-30 | Financiado
ENCORE: Evolution of Novel Contacts in Orthologous Regulatory Elements FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Thousands of Conserved Non-coding Elements (CNEs) are shared by jawed vertebrates, some of which were shown to be important developmental en...
2024-04-15 - 2027-04-30 | Financiado
HuPIPA: A Human Pancreatic Islet Perturbation Atlas (HuPIPA) to decipher diabetes-relevant regulatory networ... FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Type 2 diabetes (or T2D) is a heterogeneous disease that affects nearly 1 in 10 adults worldwide, directly causing 1.5 million deaths each y...
2024-03-11 - 2026-05-31 | Financiado
LWNVIVAT: Limiting West Nile Virus impact by novel vaccines and therapeutics approaches FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 West Nile virus (WNV) is considered one of the most widespread mosquito-borne viral disease in the world. While most of WNV infected individ...
2023-11-23 - 2027-11-30 | Financiado
EBV-MS: Targeting Epstein Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis HOGSKULEN PA VESTLANDET tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). It constitutes the most comm...
2023-11-10 - 2028-11-30 | Financiado
EOSC-ENTRUST: EOSC ENTRUST A European Network of TRUSTed research environments EUROPEAN MOLECULAR BIOLOGY LABORATORY tramitó un HORIZON EUROPE: HORIZON-INFRA-2023-EOSC-01 The mission of EOSC-ENTRUST is to create a European network of trusted research environments for sensitive data and to drive European intero...
2023-11-03 - 2027-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.